1 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Apparatus Biyze For The Treatment Of Chronic Lymphocytic Leukaemia And Marginal Zone Lymphoma Nov 05, 2024
Read More Medical New Research Shows Promise For Bone Marrow Transplant Recipient Patients To Reduce Treatment Side Effects! Nov 19, 2024
Read More Medical Significant Improvement In Survival For Pancreatic Cancer Patients! A first-Line NALIRIFOX Regimen To Look Forward To! Nov 23, 2024
